MET-097i – Talk Bio

Actionable Insights Powered by AI

Metsera Raises $275M in IPO to Advance GLP-1 Weight Loss Drug to Phase 3

3 months ago talkbio0Tagged Clinical Trials, GLP-1 receptor, IPO, MET-097i, Metsera, Obesity, Weight-Loss Agents

Metsera, IPO, GLP-1 receptor agonist, MET-097i, obesity treatment, weight loss drug, clinical trials, biotech funding

Metsera Advances with Positive Phase IIa Results for Monthly GLP-1RA Dosing

4 months ago talkbio0Tagged Clinical Trials, dosing, GLP-1RA, MET-097i, Metsera, monthly, Obesity

Metsera, GLP-1RA, MET-097i, obesity treatment, monthly dosing, weight loss, clinical trials